These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21906045)

  • 1. Age-related penetrance of hereditary atypical hemolytic uremic syndrome.
    Sullivan M; Rybicki LA; Winter A; Hoffmann MM; Reiermann S; Linke H; Arbeiter K; Patzer L; Budde K; Hoppe B; Zeier M; Lhotta K; Bock A; Wiech T; Gaspert A; Fehr T; Woznowski M; Berisha G; Malinoc A; Goek ON; Eng C; Neumann HP
    Ann Hum Genet; 2011 Nov; 75(6):639-47. PubMed ID: 21906045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.
    Sullivan M; Erlic Z; Hoffmann MM; Arbeiter K; Patzer L; Budde K; Hoppe B; Zeier M; Lhotta K; Rybicki LA; Bock A; Berisha G; Neumann HP
    Ann Hum Genet; 2010 Jan; 74(1):17-26. PubMed ID: 20059470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.
    Le Quintrec M; Roumenina L; Noris M; Frémeaux-Bacchi V
    Semin Thromb Hemost; 2010 Sep; 36(6):641-52. PubMed ID: 20865641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
    Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
    Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
    Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
    Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
    J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
    Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair.
    Couzi L; Contin-Bordes C; Marliot F; Sarrat A; Grimal P; Moreau JF; Merville P; Fremeaux-Bacchi V
    Am J Kidney Dis; 2008 Aug; 52(2):e5-9. PubMed ID: 18514989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical haemolytic uraemic syndrome.
    Kavanagh D; Goodship TH; Richards A
    Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.
    Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH
    J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
    Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual clinical severity of complement membrane cofactor protein-associated hemolytic-uremic syndrome and uniparental isodisomy.
    Fremeaux-Bacchi V; Sanlaville D; Menouer S; Blouin J; Dragon-Durey MA; Fischbach M; Vekemans M; Fridman WH
    Am J Kidney Dis; 2007 Feb; 49(2):323-9. PubMed ID: 17261436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited.
    Johnson SA; Williams JM; Hakobyan S; Richards A; Perkins SJ; Marchbank KJ; Goodship TH; Morgan BP; Taylor CM; Savage CO
    Mol Immunol; 2010 Apr; 47(7-8):1585-91. PubMed ID: 20304497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome.
    Heinen S; Sanchez-Corral P; Jackson MS; Strain L; Goodship JA; Kemp EJ; Skerka C; Jokiranta TS; Meyers K; Wagner E; Robitaille P; Esparza-Gordillo J; Rodriguez de Cordoba S; Zipfel PF; Goodship TH
    Hum Mutat; 2006 Mar; 27(3):292-3. PubMed ID: 16470555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P; Dickenmann M; Schifferli JA
    Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.